Analyst Viewpoint
Growth in health concerns over radiation exposure and rise in use of diagnostic imaging modalities are fueling the radiation dose management market size. Radiation dose management enables optimum monitoring of dosage and high accuracy in results. Rise in number of pediatric imaging procedures is also propelling market progress.
Technological advancements and easy access to radiology screening are offering lucrative radiation dose management market opportunities to companies. Leading companies in the market are forming partnerships and alliances to increase their market presence. Increase in investments in research and development activities enables companies to offer precise dose management services to diagnosis centers.
Radiation dose is the amount of energy from radiation that is actually absorbed by the body. It is important to monitor and track the amount of radiation dose injected into the body while conducting a medical procedure. Excessive dosage can create a hazardous impact on patients and also affect the results of a scan. Radiation dose management helps improve radiation protection in medical imaging and interventions. Detection of events, optimization, and imaging quality analysis are major tasks of radiation dose management.
Radiation dose management systems are widely utilized in medical imaging processes, including computed tomography, magnetic resonance imaging, and X-rays. Automatic registration and management of patient doses, information on recurrent examinations, and creation of dose reports are some of the major advantages of radiation dose management. Radiation doses help prevent adverse effects of radiation on the human body.
Excessive exposure to radiation can damage the DNA in cells. High doses of radiation can cause Acute Radiation Syndrome (ARS) or Cutaneous Radiation Injuries (CRI) and could also lead to cancer later in life. Radiation dose management helps to analyze the amount of doses required for medical imaging, depending on the duration, patient condition, and area to be diagnosed. Rise in various health concerns caused due to radiation exposure and increase in awareness about the benefits of these systems are major radiation dose management market drivers.
Increase in number of pediatric imaging procedures due to rise in health concerns among newborns is driving the demand for radiation dose management in pediatric radiology. Children are more susceptible to the potentially hazardous effects of ionizing radiation, thereby fostering market expansion.
Diagnostic imaging modalities include radiotherapy, nuclear medicine, ultrasound, medical radiation, X-rays, angiography, and Magnetic Resonance Imaging (MRI). Radiation dose management is required to monitor the appropriate dosage level according to diagnosis procedure and patient’s age. Increase in availability of radiology diagnosis procedures and rise in use of diagnostic imaging modalities are fueling the radiation dose management market development. Moreover, increase in prevalence of cancer, orthopedic, and cardiac diseases is driving market dynamics.
According to the International Agency for Research on Cancer (IARC), in 2020, around 2.3 million women were diagnosed with breast cancer, with 685,000 fatalities recorded globally. The incidence of breast cancer is projected to reach 2.74 million cases by 2030.
As per the latest radiation dose management market insights, North America dominated the global market in 2022. Well-established healthcare infrastructure, increase in awareness about radiation exposure, and technological advancements in medical diagnosis are likely to propel the radiation dose management industry share held by the region during the forecast period.
According to American Cancer Society Recommendations for the Early Detection of Cancer, women aged 40-54 should undergo regular screening mammography starting at age 45. Thus, increase in number of cancer screening procedures is driving the radiation dose management market revenue.
Leading companies providing radiation dose management services are collaborating with healthcare and diagnosis organizations to develop advanced services that ensure patient comfort and offer precise diagnosis results. Key players in the market are revising their marketing strategies in order to consolidate their position in the global market.
Some of the players in the industry are Landauer, Agfa-Gevaert Group, Sectra AB, INFINITT Healthcare Co. Ltd., Bayer AG, PACSHealth, LLC, Koninklijke Philips N.V., GE Healthcare, Thermo Fisher Scientific Inc., Medsquare SAS, Siemens, Fujifilm Holdings Corporation, and QAELUM NV.
Key players in the radiation dose management market report have been profiled based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
Attribute | Detail |
---|---|
Market Size in 2022 | US$ 237.8 Mn |
Market Forecast (Value) in 2031 | US$ 808.4 Mn |
Growth Rate (CAGR) | 14.8% |
Forecast Period | 2023-2031 |
Historical Data Available for | 2017-2021 |
Quantitative Tons | US$ Mn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available upon request |
Pricing | Available upon request |
It was valued at US$ 237.8 Mn in 2022
It is projected to expand at a CAGR of 14.8% from 2023 to 2031
Increase in health concerns over radiation exposure and rise in use of diagnostic imaging modalities
North America was the most lucrative region in 2022
Landauer, Agfa-Gevaert Group, Sectra AB, INFINITT Healthcare Co. Ltd., Bayer AG, PACSHealth, LLC, Koninklijke Philips N.V., GE Healthcare, Thermo Fisher Scientific Inc., Medsquare SAS, Siemens, Fujifilm Holdings Corporation, and QAELUM NV
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Radiation Dose Management Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Radiation Dose Management Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Radiation Dose Management Market Analysis and Forecast, by Product and Services
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product and Services, 2017–2031
6.3.1. Software
6.3.1.1. Integrated Solution
6.3.1.2. Standalone Solution
6.3.2. Services
6.4. Market Attractiveness, by Product and Services
7. Global Radiation Dose Management Market Analysis and Forecast, by Modality
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Modality, 2017–2031
7.3.1. Computed Tomography
7.3.2. Radiography and Mammography
7.3.3. Fluoroscopy and Interventional Imaging
7.3.4. Nuclear Medicine Scan
7.3.5. Others
7.3.6. 7.4 Market Attractiveness, by Modality
8. Global Radiation Dose Management Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Oncology
8.3.2. Cardiology
8.3.3. Orthopedic
8.3.4. Others
8.4. Market Attractiveness, by Application
9. Global Radiation Dose Management Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Care Settings
9.3.3. Research Organizations
9.3.4. Others
9.4. Market Attractiveness, by End-user
10. Global Radiation Dose Management Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Radiation Dose Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product and Services, 2017–2031
11.2.1. Software
11.2.1.1. Integrated Solution
11.2.1.2. Standalone Solution
11.2.2. Services
11.3. Market Attractiveness, by Product and Services
11.4. Market Value Forecast, by Modality, 2017–2031
11.4.1. Computed Tomography
11.4.2. Radiography and Mammography
11.4.3. Fluoroscopy and Interventional Imaging
11.4.4. Nuclear Medicine Scan
11.4.5. Others
11.5. Market Attractiveness, by Modality
11.6. Market Value Forecast, by Application, 2017–2031
11.6.1. Oncology
11.6.2. Cardiology
11.6.3. Orthopedic
11.6.4. Others
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals
11.8.2. Ambulatory Care Settings
11.8.3. Research Organizations
11.8.4. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product and Services
11.11.2. By Modality
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Radiation Dose Management Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product and Services, 2017–2031
12.2.1. Software
12.2.1.1. Integrated Solution
12.2.1.2. Standalone Solution
12.2.2. Services
12.3. Market Attractiveness, by Product and Services
12.4. Market Value Forecast, by Modality, 2017–2031
12.4.1. Computed Tomography
12.4.2. Radiography and Mammography
12.4.3. Fluoroscopy and Interventional Imaging
12.4.4. Nuclear Medicine Scan
12.4.5. Others
12.5. Market Attractiveness, by Modality
12.6. Market Value Forecast, by Application, 2017–2031
12.6.1. Oncology
12.6.2. Cardiology
12.6.3. Orthopedic
12.6.4. Others
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals
12.8.2. Ambulatory Care Settings
12.8.3. Research Organizations
12.8.4. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product and Services
12.11.2. By Modality
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Radiation Dose Management Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product and Services, 2017–2031
13.2.1. Software
13.2.1.1. Integrated Solution
13.2.1.2. Standalone Solution
13.2.2. Services
13.3. Market Attractiveness, by Product and Services
13.4. Market Value Forecast, by Modality, 2017–2031
13.4.1. Computed Tomography
13.4.2. Radiography and Mammography
13.4.3. Fluoroscopy and Interventional Imaging
13.4.4. Nuclear Medicine Scan
13.4.5. Others
13.5. Market Attractiveness, by Modality
13.6. Market Value Forecast, by Application, 2017–2031
13.6.1. Oncology
13.6.2. Cardiology
13.6.3. Orthopedic
13.6.4. Others
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals
13.8.2. Ambulatory Care Settings
13.8.3. Research Organizations
13.8.4. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product and Services
13.11.2. By Modality
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Radiation Dose Management Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product and Services, 2017–2031
14.2.1. Software
14.2.1.1. Integrated Solution
14.2.1.2. Standalone Solution
14.2.2. Services
14.3. Market Attractiveness, by Product and Services
14.4. Market Value Forecast, by Modality, 2017–2031
14.4.1. Computed Tomography
14.4.2. Radiography and Mammography
14.4.3. Fluoroscopy and Interventional Imaging
14.4.4. Nuclear Medicine Scan
14.4.5. Others
14.5. Market Attractiveness, by Modality
14.6. Market Value Forecast, by Application, 2017–2031
14.6.1. Oncology
14.6.2. Cardiology
14.6.3. Orthopedic
14.6.4. Others
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals
14.8.2. Ambulatory Care Settings
14.8.3. Research Organizations
14.8.4. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product and Services
14.11.2. By Modality
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Radiation Dose Management Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product and Services, 2017–2031
15.2.1. Software
15.2.1.1. Integrated Solution
15.2.1.2. Standalone Solution
15.2.2. Services
15.3. Market Attractiveness, by Product and Services
15.4. Market Value Forecast, by Modality, 2017–2031
15.4.1. Computed Tomography
15.4.2. Radiography and Mammography
15.4.3. Fluoroscopy and Interventional Imaging
15.4.4. Nuclear Medicine Scan
15.4.5. Others
15.5. Market Attractiveness, by Modality
15.6. Market Value Forecast, by Application, 2017–2031
15.6.1. Oncology
15.6.2. Cardiology
15.6.3. Orthopedic
15.6.4. Others
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals
15.8.2. Ambulatory Care Settings
15.8.3. Research Organizations
15.8.4. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product and Services
15.11.2. By Modality
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player -Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Landauer
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Agfa-Gevaert Group
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Sectra AB
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. INFINITT Healthcare Co. Ltd.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Bayer AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. PACSHealth, LLC
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Koninklijke Philips N.V.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. GE Healthcare
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Thermo Fisher Scientific, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Medsquare SAS
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Siemens
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Fujifilm Holdings Corporation
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. QAELUM NV
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
List of Tables
Table 01: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031
Table 02: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 03: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031
Table 08: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 9: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031
Table 13: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 14: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031
Table 18: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 19: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031
Table 23: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 24: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031
Table 28: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 29: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Radiation Dose Management Market Size (US$ Mn), by Region, 2022 and 2031
Figure 02: Global Radiation Dose Management Market Revenue (US$ Mn), by Product and Services, 2022
Figure 03: Global Radiation Dose Management Market Value Share, by Product and Services, 2022
Figure 04: Global Radiation Dose Management Market Revenue (US$ Mn), by Modality, 2022
Figure 05: Global Radiation Dose Management Market Value Share, by Modality, 2022
Figure 06: Global Radiation Dose Management Market Revenue (US$ Mn), by Application, 2022
Figure 07: Global Radiation Dose Management Market Value Share, by Application, 2022
Figure 08: Global Radiation Dose Management Market Revenue (US$ Mn), by End-user, 2022
Figure 09: Global Radiation Dose Management Market Value Share, by End-user, 2022
Figure 10: Global Radiation Dose Management Market Value Share, by Region, 2022
Figure 11: Global Radiation Dose Management Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: Global Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031
Figure 13: Global Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023-2031
Figure 14: Global Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031
Figure 15: Global Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023-2031
Figure 16: Global Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031
Figure 17: Global Radiation Dose Management Market Attractiveness Analysis, by Application, 2023-2031
Figure 18: Global Radiation Dose Management Market Revenue (US$ Mn), by End-user, 2022
Figure 19: Global Radiation Dose Management Market Value Share, by End-user, 2022
Figure 20: Global Radiation Dose Management Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Radiation Dose Management Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 23: North America Radiation Dose Management Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Radiation Dose Management Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031
Figure 26: North America Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031
Figure 27: North America Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031
Figure 28: North America Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: North America Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031
Figure 30: North America Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031
Figure 31: North America Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031
Figure 32: North America Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031
Figure 33: Europe Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 34: Europe Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 35: Europe Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031
Figure 37: Europe Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031
Figure 38: Europe Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031
Figure 39: Europe Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: Europe Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031
Figure 41: Europe Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031
Figure 42: Europe Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031
Figure 43: Europe Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031
Figure 44: Asia Pacific Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 45: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031
Figure 48: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031
Figure 49: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031
Figure 50: Asia Pacific Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031
Figure 52: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031
Figure 53: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031
Figure 54: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by End-user, 2022–2031
Figure 55: Latin America Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 56: Latin America Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 57: Latin America Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Latin America Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031
Figure 59: Latin America Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031
Figure 60: Latin America Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031
Figure 61: Latin America Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Latin America Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031
Figure 63: Latin America Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031
Figure 64: Latin America Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031
Figure 65: Latin America Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031
Figure 66: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 67: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 68: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031
Figure 70: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031
Figure 71: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031
Figure 72: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031
Figure 74: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031
Figure 75: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031
Figure 76: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031